Acute Admissions Rates for Lung Cancer Patients Up During Pandemic, Not Linked to COVID-19

Distressed Due to Pandemic, Patients with Lung Cancer Seek Educational Resources

Several Studies Assess the Fallout From the COVID-19 Pandemic in Patients With Lung Cancer

Post-Traumatic Stress Symptoms Found in About 25% of Patients with Cancer During COVID

Should We Delay Lung Cancer Screening During the COVID-19 Pandemic?

IASLC GENERAL DISCLAIMER

Multidisciplinary EURACAN/IASLC Proposal for Revision of the Histologic Classification of Malignant Pleural Mesothelioma 

Improving Molecular Testing in Lung Cancer: What We Learned From the IASLC Global Survey 

IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens Following Neoadjuvant Therapies

PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

Tumor Mutation Burden: Evolution of a Controversial Biomarker From the Pathologist’s Perspective

PD-L1 in Cytology Specimens